SCHEMBL8905130

SCHEMBL8905130

CCOC(=O)C(=O)N1C2=CC=CCC2CCC1C=O

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8905311 0.88 L3MBTL1 (0.33) MAPTL3MBTL1GAA
SCHEMBL8905266 0.82 L3MBTL1 (0.32) MAPTL3MBTL1GAA
SCHEMBL8904625 0.81 MAPT (0.34) MAPTL3MBTL1GAA
SCHEMBL9278165 0.76 MAPT (0.38) MAPTL3MBTL1GAALMNA
SCHEMBL8905128 0.66 ALDH1A1 (0.45) MAPTL3MBTL1GAANPSR1LMNA
SCHEMBL8649597 0.63 GAA (0.34) MAPTL3MBTL1GAA
SCHEMBL11046596 0.62 GSK3A (0.40) MAPTNPSR1
SCHEMBL8905913 0.60 KMT2A (0.33)
SCHEMBL9736803 0.56
SCHEMBL1240961 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616586-A Tricyclic quinoxalinediones SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0642508-A1 TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1995-03-15 EP disclosed
WO-1993008188-A1 TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1993-04-29 WO disclosed